We are live on ! Find out more
Ingalls & Snyder

Ingalls & Snyder Portfolio holdings

AUM $3.91B Turnover 11.18%
1-Year Est. Return 60.54%
 

Ingalls & Snyder is an investment management firm founded in 1924 by Roscoe C. Ingalls and John T. Snyder. Custom portfolio management is the core of what it offers clients, alongside wealth planning and family office services. It also manages money for institutions such as foundations and corporate retirement plans.

This Fund
S&P 500
This Quarter Est. Return
+11.84%
1 Year Est. Return
+60.54%
3 Year Est. Return
+249.52%
5 Year Est. Return
+323.37%
10 Year Est. Return
+892.94%
AUM
$3.91B
AUM Growth
+$249M
Cap. Flow
-$66M
Cap. Flow %
-1.69%
Top 10 Hldgs %
49.77%
Holding
501
New
25
Increased
103
Reduced
200
Closed
31
Avg Time Held Equity + Options
6.2 years
Top 10 Avg Time Held Equity + Options
5.5 years
Top 20 Avg Time Held Equity + Options
4.4 years
Avg Time Held Equity only
6.4 years
Top 10 Avg Time Held Equity only
5.5 years
Top 20 Avg Time Held Equity only
4.4 years

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$28.7M
2
STRS icon
STRATUS PPTYS INC
STRS
+$25.8M
3
OMER icon
Omeros
OMER
+$8.54M
4
PBI icon
Pitney Bowes
PBI
+$4.54M
5
CRS icon
Carpenter Technology
CRS
+$3.21M

Sector Composition

Rank Sector Weight
1 Healthcare 29.95%
2 Technology 12.71%
3 Energy 11.38%
4 Materials 10.96%
5 Financials 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CORT icon
1
Corcept Therapeutics
CORT
$7.88B
$884M 22.58%
7,667,798
-266,709
-3% -$28.7M
2013 Q2
53 quarters
OGC icon
2
OceanaGold Corp
OGC
$5.94B
$275M 7.02%
9,978,812
-65,465
-0.7% -$1.79M
2026 Q2
1 quarter
AAPL icon
3
Apple
AAPL
$5.18T
$112M 2.87%
337,522
-1,665
-0.5% -$535K
2020 Q4
23 quarters
XOM icon
4
ExxonMobil
XOM
$696B
$109M 2.79%
671,693
-1,612
-0.2% -$252K
2013 Q2
53 quarters
CNQ icon
5
Canadian Natural Resources
CNQ
$101B
$105M 2.67%
2,220,691
-20,119
-0.9% -$948K
2013 Q2
53 quarters
MSFT icon
6
Microsoft
MSFT
$3.89T
$103M 2.64%
201,094
+2,492
+1% +$1.15M
2013 Q2
53 quarters
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$3.64T
$102M 2.6%
295,305
-2,674
-0.9% -$928K
2015 Q4
43 quarters
WMB icon
8
Williams Companies
WMB
$86.4B
$93.1M 2.38%
1,369,133
+2,596
+0.2% +$189K
2013 Q2
53 quarters
BRK.B icon
9
Berkshire Hathaway Class B
BRK.B
$1.26T
$85.6M 2.19%
171,895
-581
-0.3% -$293K
2020 Q4
23 quarters
PAAS icon
10
Pan American Silver
PAAS
$15.5B
$79.6M 2.03%
1,748,149
-16,508
-0.9% -$788K
2019 Q2
29 quarters
JPM icon
11
JPMorgan Chase
JPM
$919B
$62.1M 1.59%
187,756
-3,542
-2% -$1.24M
2013 Q2
53 quarters
OMER icon
12
Omeros
OMER
$1.27B
$58.9M 1.51%
3,095,323
-564,200
-15% -$8.54M
2013 Q2
53 quarters
AMZN icon
13
Amazon
AMZN
$2.88T
$54.7M 1.4%
219,641
+1,621
+0.7% +$412K
2020 Q4
23 quarters
NVDA icon
14
NVIDIA
NVDA
$3.93T
$52M 1.33%
227,908
-482
-0.2% -$103K
2017 Q2
37 quarters
GOOG icon
15
Alphabet (Google) Class C
GOOG
$3.6T
$50.1M 1.28%
147,113
-1,288
-0.9% -$444K
2013 Q2
53 quarters
DE icon
16
Deere & Co
DE
$182B
$42.2M 1.08%
62,808
-488
-0.8% -$310K
2013 Q2
53 quarters
META icon
17
Meta Platforms (Facebook)
META
$1.64T
$38.6M 0.99%
53,225
+8,595
+19% +$5.36M
2015 Q3
44 quarters
EXPE icon
18
Expedia Group
EXPE
$30.6B
$36.7M 0.94%
139,296
-1,166
-0.8% -$339K
2023 Q2
13 quarters
ABBV icon
19
AbbVie
ABBV
$521B
$35.6M 0.91%
136,079
+221
+0.2% +$56.7K
2013 Q2
53 quarters
PG icon
20
Procter & Gamble
PG
$394B
$32.2M 0.82%
221,332
-2,131
-1% -$312K
2013 Q2
53 quarters
ABT icon
21
Abbott
ABT
$188B
$31.8M 0.81%
321,998
+5,318
+2% +$555K
2020 Q4
23 quarters
C icon
22
Citigroup
C
$205B
$28.9M 0.74%
223,212
-12,057
-5% -$1.62M
2016 Q3
40 quarters
MRK icon
23
Merck
MRK
$364B
$28.9M 0.74%
198,809
-5,164
-3% -$714K
2013 Q2
53 quarters
RTX icon
24
RTX Corp
RTX
$268B
$28.7M 0.73%
154,635
-3,528
-2% -$722K
2020 Q4
23 quarters
RRC icon
25
Range Resources
RRC
$12.1B
$28.7M 0.73%
773,550
-20,000
-3% -$785K
2013 Q2
53 quarters

Similar funds

Ingalls & Snyder's Q3 2026 Portfolio in Review

As of Q3 2026, Ingalls & Snyder held 501 positions worth $3.91B, up 6.8% from $3.66B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Ingalls & Snyder's Q3 2026 filing shows 25 new, 103 increased, 200 reduced and 31 closed positions. Its largest new stake was Howmet Aerospace: 6,486 shares worth $1.47M. The largest sale was Corcept Therapeutics, an estimated $28.7M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 26% a quarter earlier, followed by Technology and Energy.

  • Ingalls & Snyder's largest Q3 2026 buy was Howmet Aerospace: 6,486 shares worth $1.47M.
  • Ingalls & Snyder added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $11.5M increase.
  • Ingalls & Snyder's biggest Q3 2026 reduction was Corcept Therapeutics, cutting an estimated $28.7M.
  • Ingalls & Snyder fully exited STRATUS PPTYS INC in Q3 2026, selling an estimated $25.8M.
  • Ingalls & Snyder's ten largest holdings make up 50% of its $3.91B portfolio in Q3 2026.
  • Ingalls & Snyder opened 25 new positions and closed 31 in Q3 2026.
  • Ingalls & Snyder's portfolio value rose 6.8% quarter-over-quarter to $3.91B.

Based on Ingalls & Snyder's 13F filing for Q3 2026, filed 12 Nov 2026.